查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808835

數位生物製造市場，按生物製劑類型、按部署類型、按應用、按技術、按最終用戶、按國家和地區分類 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Digital Biomanufacturing Market, By Biologic Type, By Deployment Type, By Application, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 367 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年數位生物製造市場規模價值 212.3465 億美元，2025 年至 2032 年的複合年成長率為 9.5%。

數位化生物製造是將人工智慧、機器學習、資料分析和自動化等數位技術融入生物生產流程。它能夠提高生物製劑、疫苗以及細胞和基因療法生產的效率、精確度和可擴展性。透過實現即時監控、預測性維護和流程最佳化，數位化生物製造能夠提高產品品質、降低成本並加快開發進度，從而徹底改變生物技術和製藥生產的未來。

數位生物製造市場-市場動態

生物製劑需求的不斷成長預計將推動市場需求

生物製劑需求的不斷成長正在加速製造業的數位轉型。美國食品藥物管理局 (FDA) 報告稱，2023 年生物製劑佔新藥核准的 45% 以上。此外，政府對智慧製造的日益重視也推動了數位化生物製造的應用。然而，複雜的監管合規和高昂的資本投入是全球數位化生物製造市場發展的主要障礙。相反，人工智慧在製造業的擴張為市場成長提供了巨大的機會。此外，支持創新的公共資金也不斷增加，包括數位基礎設施和自動化領域。

數位生物製造市場—關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 9.5%。

根據生物製劑類型細分，預計抗體將在 2024 年佔據最大市場佔有率

根據部署類型細分，本地部署是 2024 年的主要部署類型

根據應用細分，生物製造過程自動化是 2024 年的主要應用

根據技術細分，過程分析技術（PAT）是2024年的領先技術

根據最終用戶細分，生物製藥公司是 2024 年領先的最終用戶

從地區來看，北美是 2024 年最大的收入來源

數位生物製造市場-細分分析：

全球數位生物製造市場根據生物類型、部署類型、應用、技術、最終用戶和地區進行細分。

根據生物製劑類型，市場分為四類：抗體、疫苗、細胞和基因療法以及其他。預計抗體領域將在預測期內佔據主要市場佔有率。這是由於其在治療癌症和自體免疫疾病等慢性疾病方面應用廣泛，且產量高且對單株抗體的需求持續成長。

根據應用，市場可分為四大類：數位生物反應器規模化、遠端設備監控、生物製造流程自動化及其他。生物製造過程自動化領域預計將佔據主要市場佔有率。這種主導地位源自於對提高效率、減少人為錯誤和簡化複雜生產流程的需求。

數位生物製造市場-地理洞察

在先進的生物技術基礎設施、強大的政府資金以及人工智慧和自動化技術的早期採用的推動下，預計北美將在預測期內佔據全球數位生物製造市場的主要市場佔有率。

另一方面，預計亞太地區將以最快的速度成長，這得益於生物製藥製造中心的擴大、數位醫療技術投資的增加以及中國、印度和韓國等國家的政府支持措施。

數位生物製造市場-競爭格局：

對更快、更精準的生物製劑生產的需求日益成長，這推動了競爭，促使企業採用以數位整合、自動化和即時分析為中心的策略。企業正在投資智慧製造平台、人工智慧驅動的流程控制和數位孿生技術，以最佳化生產效率並縮短產品上市時間。與技術供應商的策略合作、基於雲端的解決方案的擴展以及模組化生物生產系統的開發也日益受到關注，使企業能夠提高靈活性、確保合規性，並在不斷變化的行業格局中保持競爭優勢。

最新動態：

2025 年 4 月，Sartorius Stedim Biotech 與 Tulip Interfaces 合作推出 Biobrain(R) Operate，這是一款無程式碼數位套件，透過與 Sartorius 設備無縫整合來增強一次性生物處理，加速生物製藥製造的數位轉型。

目錄

第1章：數位生物製造市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 按生物製劑類型分類的數位生物製造市場片段
    • 按部署類型分類的數位生物製造市場片段
    • 數位生物製造市場片段（按應用）
    • 數位生物製造市場技術片段
    • 最終用戶的數位生物製造市場片段
    • 各國數位生物製造市場概況
    • 數位化生物製造市場（按地區）
  • 競爭洞察

第3章：數位化生物製造關鍵市場趨勢

  • 數位生物製造市場促進因素
    • 市場促進因素的影響分析
  • 數位生物製造市場限制
    • 市場限制的影響分析
  • 數位生物製造市場機遇
  • 數位生物製造市場未來趨勢

第4章：數位化生物製造業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：數位生物製造市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：數位生物製造市場格局

  • 2024年數位生物製造市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：數位生物製造市場－依生物製劑類型

  • 概述
    • 按生物製劑類型分類的細分市場佔有率分析
    • 抗體
    • 疫苗
    • 細胞和基因療法
    • 其他

第 8 章：數位生物製造市場 - 按部署類型

  • 概述
    • 按部署類型分類的細分市場佔有率分析
    • 本地
    • 基於雲端

第9章：數位生物製造市場－按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 數位生物反應器規模化
    • 遠端設備監控
    • 生物製造流程自動化
    • 其他

第 10 章：數位生物製造市場 - 按技術

  • 概述
    • 按技術細分的市場佔有率分析
    • 過程分析技術（PAT）
    • 製造執行系統（MES）
    • 數位孿生
    • 數據分析軟體

第 11 章：數位生物製造市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 合約製造組織
    • 生物製藥公司
    • 其他

第 12 章：數位生物製造市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美數位生物製造主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（依生物製劑類型）
    • 北美市場規模和預測（按部署類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲數位生物製造主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（依生物製劑類型）
    • 歐洲市場規模及預測（按部署類型）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區數位生物製造主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依生物製劑類型）
    • 亞太地區市場規模及預測（依部署類型）
    • 亞太地區市場規模及預測（按應用）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲數位生物製造主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依生物製劑類型）
    • 拉丁美洲市場規模及預測（按部署類型）
    • 拉丁美洲市場規模及預測（按應用）
    • 拉丁美洲市場規模及預測（按技術）
    • LATAM 規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲的數位生物製造關鍵製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按生物製劑類型）
    • 中東和非洲市場規模及預測（按部署類型）
    • 中東和非洲市場規模和預測（按應用）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 13 章：關鍵供應商分析-數位生物製造業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Atos SE
    • Danaher Corporation
    • Agilent Technologies Inc.
    • Donaldson Company, Inc.
    • General Electric Company
    • Emerson Electric Co.
    • Honeywell International Inc.
    • Siemens Healthineers AG
    • SAP SE
    • Bota Biosciences
    • e-matica srl
    • Culture Biosciences
    • Exponential Genomics, Inc.
    • OVO Biomanufacturing
    • FabricNano
    • Symphony Innovation, LLC
    • Ample Logic
    • Thermo Fisher Scientific
    • Bruker
    • ABB
    • Dassault Systems
    • Hamilton Company
    • Invert, Inc.
    • Eppendorf SE
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5499

Digital biomanufacturing market size was valued at US$ 21,234.65 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

Digital biomanufacturing is the integration of digital technologies, such as artificial intelligence, machine learning, data analytics, and automation, into biological production processes. It enhances efficiency, precision, and scalability in the manufacturing of biologics, vaccines, and cell and gene therapies. By enabling real-time monitoring, predictive maintenance, and process optimization, digital biomanufacturing improves product quality, reduces costs, and accelerates development timelines, revolutionizing the future of biotechnology and pharmaceutical production.

Digital Biomanufacturing Market- Market Dynamics

Increasing demand for biologics is expected to propel the market demand

Rising demand for biologics is accelerating digital transformation in manufacturing, with the U.S. FDA reporting that biologics accounted for over 45% of new drug approvals in 2023. Besides, the growing government focus on smart manufacturing is driving the adoption of digital biomanufacturing. However, complex regulatory compliance and high capital investment are major barriers for the global digital biomanufacturing market. On the contrary, the expansion of AI in manufacturing presents a strong opportunity for market growth. Moreover, supportive public funding for innovation is growing, including digital infrastructure and automation.

Digital Biomanufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2025-2032)

Based on Biologic Type segmentation, antibodies were predicted to show maximum market share in the year 2024

Based on Deployment Type segmentation, on-premises was the leading Deployment Type in 2024

Based on Application segmentation, biomanufacturing process automation was the leading Application in 2024

Based on technology segmentation, process analytical technology (PAT) was the leading technology in 2024

Based on end user segmentation, biopharmaceutical companies were the leading end user in 2024

Based on region, North America was the leading revenue generator in 2024

Digital Biomanufacturing Market- Segmentation Analysis:

The Global Digital Biomanufacturing Market is segmented on the basis of Biologic Type, Deployment Type, Application, Technology, End User, and Region.

The market is divided into four categories based on Biologic Type: antibodies, vaccines, cell & gene therapies, and others. The antibodies segment is expected to hold the major market share during the forecast period. This is due to their widespread use in treating chronic diseases like cancer and autoimmune disorders, along with high production volumes and continuous demand for monoclonal antibodies.

The market is divided into four categories based on Application: digital bioreactor scaling, remote equipment monitoring, biomanufacturing process automation, and others. The biomanufacturing process automation segment is expected to hold the major market share. This dominance is driven by the need to enhance efficiency, reduce human error, and streamline complex production workflows.

Digital Biomanufacturing Market- Geographical Insights

North America is expected to hold the major market share in the global digital biomanufacturing market during the forecast period, driven by advanced biotechnology infrastructure, strong government funding, and early adoption of AI and automation technologies.

On the other hand, Asia-Pacific is projected to grow at the fastest rate, fueled by expanding biopharmaceutical manufacturing hubs, increasing investments in digital healthcare technologies, and supportive government initiatives in countries like China, India, and South Korea.

Digital Biomanufacturing Market- Competitive Landscape:

Growing demand for faster and more precise biologics production is driving competition, prompting companies to adopt strategies centered on digital integration, automation, and real-time analytics. Firms are investing in smart manufacturing platforms, AI-driven process control, and digital twins to optimize production efficiency and reduce time-to-market. Strategic collaborations with tech providers, expansion of cloud-based solutions, and development of modular bioproduction systems are also gaining traction, enabling players to enhance flexibility, ensure regulatory compliance, and maintain a competitive edge in an evolving industry landscape.

Recent Developments:

In April 2025, Sartorius Stedim Biotech partnered with Tulip Interfaces to launch Biobrain(R) Operate, a no-code digital suite enhancing single-use bioprocessing by integrating seamlessly with Sartorius equipment, accelerating digital transformation in biopharmaceutical manufacturing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL BIOMANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Atos SE
  • Danaher Corporation
  • Agilent Technologies Inc.
  • Donaldson Company, Inc.
  • General Electric Company
  • Emerson Electric Co.
  • Honeywell International Inc.
  • Siemens Healthineers AG
  • SAP SE
  • Bota Biosciences
  • e-matica srl
  • Culture Biosciences
  • Exponential Genomics, Inc.
  • OVO Biomanufacturing
  • FabricNano
  • Symphony Innovation, LLC
  • Ample Logic
  • Thermo Fisher Scientific
  • Bruker
  • ABB
  • Dassault Systems
  • Hamilton Company
  • Invert, Inc.
  • Eppendorf SE
  • Others

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY BIOLOGIC TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antibodies
  • Vaccines
  • Cell & Gene Therapies
  • Others

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY DEPLOYMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • On-premises
  • Cloud-based

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Digital Bioreactor Scaling
  • Remote Equipment Monitoring
  • Biomanufacturing Process Automation
  • Others

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Process Analytical Technology (PAT)
  • Manufacturing Execution System (MES)
  • Digital Twins
  • Data Analytics Software

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Contract Manufacturing Organizations
  • Biopharmaceutical Companies
  • Others

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Digital Biomanufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Digital Biomanufacturing Market Snippet by Biologic Type
    • 2.1.2. Digital Biomanufacturing Market Snippet by Deployment Type
    • 2.1.3. Digital Biomanufacturing Market Snippet by Application
    • 2.1.4. Digital Biomanufacturing Market Snippet by Technology
    • 2.1.5. Digital Biomanufacturing Market Snippet by End User
    • 2.1.6. Digital Biomanufacturing Market Snippet by Country
    • 2.1.7. Digital Biomanufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Digital Biomanufacturing Key Market Trends

  • 3.1. Digital Biomanufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Digital Biomanufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Digital Biomanufacturing Market Opportunities
  • 3.4. Digital Biomanufacturing Market Future Trends

4. Digital Biomanufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Digital Biomanufacturing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Digital Biomanufacturing Market Landscape

  • 6.1. Digital Biomanufacturing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Digital Biomanufacturing Market - By Biologic Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Biologic Type, 2024 & 2032 (%)
    • 7.1.2. Antibodies
    • 7.1.3. Vaccines
    • 7.1.4. Cell & Gene Therapies
    • 7.1.5. Others

8. Digital Biomanufacturing Market - By Deployment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment Type, 2024 & 2032 (%)
    • 8.1.2. On-premises
    • 8.1.3. Cloud-based

9. Digital Biomanufacturing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Digital Bioreactor Scaling
    • 9.1.3. Remote Equipment Monitoring
    • 9.1.4. Biomanufacturing Process Automation
    • 9.1.5. Others

10. Digital Biomanufacturing Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 10.1.2. Process Analytical Technology (PAT)
    • 10.1.3. Manufacturing Execution System (MES)
    • 10.1.4. Digital Twins
    • 10.1.5. Data Analytics Software

11. Digital Biomanufacturing Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Contract Manufacturing Organizations
    • 11.1.3. Biopharmaceutical Companies
    • 11.1.4. Others

12. Digital Biomanufacturing Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Digital Biomanufacturing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Digital Biomanufacturing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Digital Biomanufacturing Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Digital Biomanufacturing Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Digital Biomanufacturing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Digital Biomanufacturing Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Atos SE
    • 13.2.2. Danaher Corporation
    • 13.2.3. Agilent Technologies Inc.
    • 13.2.4. Donaldson Company, Inc.
    • 13.2.5. General Electric Company
    • 13.2.6. Emerson Electric Co.
    • 13.2.7. Honeywell International Inc.
    • 13.2.8. Siemens Healthineers AG
    • 13.2.9. SAP SE
    • 13.2.10. Bota Biosciences
    • 13.2.11. e-matica srl
    • 13.2.12. Culture Biosciences
    • 13.2.13. Exponential Genomics, Inc.
    • 13.2.14. OVO Biomanufacturing
    • 13.2.15. FabricNano
    • 13.2.16. Symphony Innovation, LLC
    • 13.2.17. Ample Logic
    • 13.2.18. Thermo Fisher Scientific
    • 13.2.19. Bruker
    • 13.2.20. ABB
    • 13.2.21. Dassault Systems
    • 13.2.22. Hamilton Company
    • 13.2.23. Invert, Inc.
    • 13.2.24. Eppendorf SE
    • 13.2.25. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us